Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
Ingrid A.W. van Rijsingen(Amsterdam UMC Location University of Amsterdam), Yigal M. Pinto(Maastricht University Medical Centre), Perry Elliott(UCL Australia), Michele Pasotti(Policlinico San Matteo Fondazione), Philippe Charron(Laboratoire National de Référence), Sabine Pankuweit(Universitätsklinikum Gießen und Marburg), Andrea Pilotto(Fondazione Europea Ricerca Biomedica), Uzma Aslam(Sorbonne Université), Jens Mogensen(Odense University Hospital), Eloisa Arbustini, Camilla Rowland(University College Hospital at Westmoreland Street), Andreas Perrot(Max Delbrück Center), Anneke J. van der Kooi(Amsterdam UMC Location University of Amsterdam), J.F. Hermans-van Ast(Netherlands Heart Institute), Maarten P. van den Berg(University Medical Center Groningen), J. Peter van Tintelen, Sharon Jenkins(University College Hospital at Westmoreland Street), Aeilko H. Zwinderman(GGD Amsterdam), Arthur A.M. Wilde
Cited by 516
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k